Publications
- 
                        Felipe, DF, Casas-Alba D, Sadok, SH, Fernández-Pérez MT, Vega-Hanna, L, Plaza, L, Vicente-Villa MA, Armstrong-Moron J, Guillén-Navarro, E and Martinez-Monseny T. Unveiling the Spectrum: Clinical and Molecular Insights from a Spanish Pediatric Cohort with Hypermobility Disorders and Ehlers-Danlos SyndromeGENES . 16(8): . 
- 
                        Siqueira E, Velasco CD, Tarrasón A, Soler M, Srinivas T, Setién F, Oliveira-Mateos C, Casado-Pelaez M, Martinez-Verbo L, Armstrong-Moron J, Esteller M, Alves LF, Llobet A and Guil S. NEAT1-mediated regulation of proteostasis and mRNA localization impacts autophagy dysregulation in Rett syndromeNUCLEIC ACIDS RESEARCH . 53(4): . Number of citations: 2 
- 
                        Vega-Hanna L, Casas-Alba D, Balsells S, Bolasell M, Rubio P, García-García AP, García-García O, O'Callaghan-Gordo M, Pascual-Alonso A, Armstrong-Moron J, Mds Group and Martinez-Monseny T. MECP2 Duplication Syndrome: AI-Based Diagnosis, Severity Scale Development and Correlation with Clinical and Molecular VariablesDiagnostics . 15(1): . Number of citations: 1 
- 
                        Barbera, Anna Revert, Martorell, Loreto, Boix Lluch C, Armstrong-Moron J, Carrera, Laura, Nascimento-Osorio A and Ortigoza-Escobar JD. Clinical Response of Levodopa in CTNNB1 -Related DystoniaJournal of Pediatric Neurology . 22(06): 466-469. 
- 
                        Pascual-Alonso A, Xiol-Viñas C, Smirnov D, Kopajtich R, Prokisch H and Armstrong-Moron J. Multi-omics in MECP2 duplication syndrome patients and carriersEUROPEAN JOURNAL OF NEUROSCIENCE . 60(2): 4004-4018. Number of citations: 3 
- 
                        Revencu N, Eijkelenboom A, Bracquemart C, Alhopuro P, Armstrong-Moron J, Baselga E, Cesario C, Dentici ML, Eyries M, Frisk S, Karstensen HG, Gene-Olaciregui N, Kivirikko S, Lavarino C, Mero IL, Michiels R, Pisaneschi E, Schönewolf-Greulich B, Wieland I, Zenker M and Vikkula M. Assessment of gene-disease associations and recommendations for genetic testing for somatic variants in vascular anomalies by VASCERN-VASCAORPHANET JOURNAL OF RARE DISEASES . 19(1): 213-213. Number of citations: 9 
- 
                        Illescas S, Díaz-Osorio Y, Serradell A, Toro-Soria L, Musokhranova U, Julià-Palacios NA, Ribeiro J, Altafaj X, Olivella M, O'Callaghan-Gordo M, Darling A, Armstrong-Moron J, Artuch-Iriberri R, Garcia-Cazorla A and De Oyarzabal-Sanz AL. Metabolic characterization of neurogenetic disorders involving glutamatergic neurotransmissionJOURNAL OF INHERITED METABOLIC DISEASE . 47(3): 551-569. Number of citations: 3 
- 
                        Brooks D, Burke E, Lee S, Eble TN, O'Leary M, Osei-Owusu I, Rehm HL, Dhar SU, Emrick L, Bick D, Nehrebecky M, Macnamara E, Casas-Alba D, Armstrong-Moron J, Prat-Torres CS, Martinez-Monseny T, Palau F, Liu P, Adams D, Lalani S, Rosenfeld JA and Burrage LC. Heterozygous MAP3K20 variants cause ectodermal dysplasia, craniosynostosis, sensorineural hearing loss, and limb anomaliesHUMAN GENETICS . 143(3): 279-291. Number of citations: 5 
- 
                        Domínguez-Carral J, Ludlam WG, Junyent Segarra M, Fornaguera Marti M, Balsells S, Muchart-Lopez J, Cokolic Petrovic D, Espinoza I, Ortigoza-Escobar JD and Martemyanov KA. Severity of GNAO1-Related Disorder Correlates with Changes in G-Protein FunctionANNALS OF NEUROLOGY . 94(5): 987-1004. Number of citations: 21 
- 
                        Pascual-Alonso A, Xiol-Viñas C, Smirnov D, Kopajtich R, Prokisch H and Armstrong-Moron J. Identification of molecular signatures and pathways involved in Rett syndrome using a multi-omics approachHUMAN GENOMICS . 17(1): 85-85. Number of citations: 7 
